Ted D. Meisel - 27 Oct 2021 Form 4 Insider Report for SomaLogic, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 27 Oct 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Dec 2021, 15:57:40 UTC
Prior SEC filing: 10 Sep 2021
Next SEC filing: 03 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Ruben Gutierrez, as attorney-in-fact

Key filing fact

Ted D. Meisel filed Form 4 for SomaLogic, Inc. on 13 Dec 2021.

Key facts

This page summarizes Ted D. Meisel's Form 4 filing for SomaLogic, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Dec 2021, 15:57.

Change

Previous filing in this sequence was filed on 10 Sep 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLGC transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +46,705
Change %
Price: $0.000000
Shares after: 46,705
Date: 27 Oct 2021
Ownership: Direct
Underlying class: Common Stock, par value $0.0001
Underlying amount: 46,705
Exercise price: $11.85
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares underlying the option vest one year after the grant date, then the remaining shares vest in equal monthly installments thereafter starting on the 1st of following full month until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.